Bhavin Bhagat has been elevated to the role of Chief Financial Officer at CORONA Remedies Limited. With an vast career in the pharmaceutical industry, Bhavin is renowned for his expertise in corporate strategy, financial management, treasury, risk assurance, mergers and acquisitions, and corporate affairs. His promotion marks a significant milestone in his career, where he is now tasked with leading the financial strategy and operational direction of the company as it continues to grow and innovate in the healthcare sector.
Prior to his elevation to CFO, Bhavin served as President at CORONA Remedies Limited, overseeing key financial and operational functions that supported the company’s strategic goals. He has been an integral part of the organization for over a decade, beginning as Vice President, where he contributed significantly to shaping business finance strategies and managing crucial corporate relationships. His comprehensive understanding of corporate finance, coupled with his hands-on experience in handling audits, due diligence, and financial consolidation, has been pivotal in driving the company’s success.
Bhavin’s vast experience spans not only the leadership roles he held at CORONA but also his tenure at Claris Lifesciences Limited, where he worked as Senior Manager in Accounts & Business Finance. His work at Claris involved managing the consolidation of accounts for both parent and subsidiary companies, transfer pricing, audits, and due diligence activities. This foundation in financial operations has further honed his ability to navigate the complexities of the pharmaceutical industry.
His credentials include a Chartered Accountant qualification from The Institute of Chartered Accountants of India and a Master’s Degree in Cost Management Accountancy. Additionally, his executive education from IIM Calcutta in financial economics and strategy has enhanced his strategic vision and leadership in managing financial operations at the highest level.
Bhavin’s networking skills keep his adrenaline rush high, as he actively engages with key people in the industry, fostering continuous self-development. His efforts have led him to work on several functional platforms in the pharmaceutical industry, earning him features in Global Business Reports (GBR) on the cover title report on “India Pharmaceutical Industry” in both 2019 and 2020.
As CFO, Bhavin will continue to build upon his past experiences, driving the financial stability and growth of CORONA Remedies Limited. His leadership will be crucial in executing corporate strategies, managing investments, and leading financial teams to ensure the company remains on track for sustained growth in the competitive pharmaceutical sector.
Bhavin is also known for his commitment to corporate social responsibility, actively engaging in initiatives such as blood donation drives and participating in global industry events like CPhI Worldwide. His involvement in these efforts further reflects his passion for making a positive impact both within and outside the organization.
Bhavin Bhagat’s elevation to CFO at CORONA Remedies Limited signals a bright future for both him and the company, as he brings his extensive experience, strategic acumen, and leadership to the forefront of the organization’s next phase of growth.